Literature DB >> 18987542

Pancreatic acinar tissue in liver explants: a morphologic and immunohistochemical study.

Fang-Ying Kuo1, Paul E Swanson, Matthew M Yeh.   

Abstract

BACKGROUND: Pancreatic acini-like tissue is occasionally seen in the liver. It is uncertain whether its presence represents heterotopia or metaplasia. To gain further insight into this issue, we performed a pathologic and immunohistochemical study in liver explants to identify pancreatic acinar tissue.
DESIGN: A total of 382 liver explants transplanted from 1995 to 2000 were examined. Formalin-fixed, paraffin-embedded tissues were stained with hematoxylin-eosin, and immunohistochemical analyses using antibodies against CK7, CK8, and CK19 (biliary type cytokeratins), CD56 (positive in reactive bile ductules), chromogranin A (positive in reactive bile ductules and human oval-like/hepatic progenitor cells), pancreatic amylase, and PDX-1 were performed. The immunohistochemical comparison group consisted of 3 gastric biopsies diagnosed as autoimmune gastritis with pancreatic metaplasia and 3 normal pancreatic tissues from pancreatectomy specimens.
RESULTS: Sixteen (4.2%) of 382 liver explants contained pancreatic acini-like tissue. Fifteen of these were cirrhotic livers due to cryptogenic cirrhosis (n=1), primary biliary cirrhosis (n=3), primary sclerosing cholangitis (n=1), chronic hepatitis C-related cirrhosis (n=5), and cirrhosis with hepatitis C and hepatocellular carcinoma (n=5). There was 1 noncirrhotic explant, the result of isoniazid hepatotoxicity. The pancreatic acini-like tissue appeared as small clusters of compactly packed cells that either blended imperceptibly with or were in close proximity to adjacent bile ducts or ductules. The pancreatic acinar tissue was diffusely reactive for amylase, was occasionally positive for keratin 8 and chromogranin A, and was negative for CD56, keratin 7, and keratin 19. Biliary type epithelium (bile ducts and ductules) and the ductules within the acini was always diffusely positive for keratin 7, 8, and 19, occasionally reactive for CD56 and chromogranin A, and typically negative for amylase.
CONCLUSIONS: Our results collectively indicate that pancreatic acini-like tissue in liver represent aggregates of pancreatic acinar cells admixed with small intra-acinar terminal ductules. Given the close spatial relationship with reactive bile ductules and the apparent transition in immunophenotype from bile ductules to pancreatic acinar tissue, the latter is likely of metaplastic origin derived from a hepatic progenitor lineage.

Entities:  

Mesh:

Year:  2009        PMID: 18987542     DOI: 10.1097/PAS.0b013e31818c8482

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

1.  Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes.

Authors:  Branden D Tarlow; Carl Pelz; Willscott E Naugler; Leslie Wakefield; Elizabeth M Wilson; Milton J Finegold; Markus Grompe
Journal:  Cell Stem Cell       Date:  2014-10-09       Impact factor: 24.633

2.  Intestinal metaplasia in liver of rats after partial hepatectomy and treatment with acetylaminofluorene.

Authors:  V Barut; C E Sarraf
Journal:  Cell Prolif       Date:  2009-07-17       Impact factor: 6.831

3.  Human fetal ductal plate revisited: II. MUC1, MUC5AC, and MUC6 are expressed in human fetal ductal plate and MUC1 is expressed also in remodeling ductal plate, remodeled ductal plate and mature bile ducts of human fetal livers.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

Review 4.  Hepatolithiasis associated with intrahepatic heterotopic pancreas: a case report and literature review.

Authors:  Zhi-Yong Yu; Zhong-Quan Sun; Min Zhang; Bei Wang; Wen Lu; Shu-Sen Zheng
Journal:  Diagn Pathol       Date:  2015-06-23       Impact factor: 2.644

5.  Cytopathology and ultrastructure identification of primary hepatic acinar cell carcinoma: Case report.

Authors:  J G Grab; D Skubleny; N M Kneteman
Journal:  Int J Surg Case Rep       Date:  2019-08-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.